603939.SS Overview

Company Profile

Related stocks

603233.SS • China

DASHENLIN PHARMACEUTICAL GROUP

18.76 CNY

3.2B USD 1Y +12.9%

603883.SS • China

LBX PHARMACY CHAIN JOINT STOCK

13.53 CNY

1.54B USD 1Y -18.1%

3391.T • Japan

TSURUHA HOLDINGS INC

2,123.5 JPY

6.09B USD 1Y -13.5%

7649.T • Japan

SUGI HOLDINGS CO.LTD.

1,227.5 JPY

2.89B USD 1Y -27.4%

3349.T • Japan

COSMOS PHARMACEUTICAL CORP

6,392 JPY

3.2B USD 1Y -23.8%

9989.T • Japan

SUNDRUG CO LTD

3,530 JPY

2.61B USD 1Y -16.5%

3549.T • Japan

KUSURI NO AOKI HOLDINGS CO LTD

4,138 JPY

2.48B USD 1Y +12%

002727.SZ • China

YIXINTANG

10.99 CNY

963.01M USD 1Y -20.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

China

Region

Asia-Pacific

Sector

Healthcare

Industry

Pharmaceutical Retailers

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

38.2% p.a.

Max Drawdown (5Y)

-64.9%

Sharpe Ratio (5Y)

-0.30

Beta Factor

0.26

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.2% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -70.2% in the extended horizon.